|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.20 EUR | +0.73% |
|
-3.68% | -18.22% |
| 04-10 | AlphaValue Urges Patience on bioMérieux, Maintains Buy Rating |  |
| 04-09 | BioMérieux Unveils Biofire Spotfire Molecular Testing Solution For The Pharmaceutical Industry | CI |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 13 | |||||||
| 22 | |||||||
| 11 | |||||||
| 10 | |||||||
| - | - | - | - | ||||
| 13 | |||||||
| 12 | |||||||
| 13 | |||||||
| 3 | |||||||
| - | - | ||||||
| - | - | ||||||
| 1 | |||||||
| 5 | |||||||
| 3 | |||||||
| - | 1 | ||||||
| - | 1 | ||||||
| - | - | ||||||
| - | - | ||||||
| Average | 8 | |||||||
| Weighted average by Cap. | 13 |
- Stock Market
- Equities
- BIM Stock
- Sector bioMérieux
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition